Glimepiride CAS 93479-97-1 Assay 98.0%~102.0% API Factory High Purity Whakaaturanga Whakaahua

Glimepiride CAS 93479-97-1 Assay 98.0%~102.0% API Factory High Pure

Whakaahuatanga Poto:

Ingoa matū: Glimepiride

CAS: 93479-97-1

Te ahua: Paura ma, tata ma ranei

Whakatau: 98.0%~102.0%

Glimepiride i roto i te maimoatanga o te Noninsulin-Dependent Type 2 Diabetes Mellitus

API Kounga Teitei, Hanganga Tauhokohoko

Inquiry: alvin@ruifuchem.com

Tukuna he imeera ki a matou

Taipitopito Hua

Hua e Pa ana

Tohu Hua

Whakaahuatanga:

Whakarato me te Maama me te Kounga Pumau
Ingoa matū: Glimepiride
CAS: 93479-97-1
Glimepiride i roto i te maimoatanga o te Noninsulin-Dependent Type 2 Diabetes Mellitus
API Kounga Teitei, Hanganga Tauhokohoko

Ngā Āhuatanga matū:

Ingoa matū	Glimepiride
Nga kupu taurite	Amaryl
Tau CAS	93479-97-1
Tau CAT	RF-API24
Tūnga Taonga	I roto i te Stock, Production Tauine Up ki Taranata
Tātai rāpoi	C24H34N4O5S
Taumaha rāpoi	490.62
Iwi Whakarewa	212.2~214.5℃
Tikanga Tukunga	I raro i te Paemahana Ambient
Waitohu	Ruifu Chemical

Whakatakotoranga:

Tūemi	Whakatakotoranga
Te ahua	Paura ma, tata ma ranei
Tautuhinga	IR (He rite ki te Paerewa)
Nga Taonga Paanga
Cis-Isomer (A)	≤0.80%
Sulfonamide (B)	≤0.40%
Uretana (C)	≤0.10%
3-Isomer (D)	≤0.20%
Tetahi atu poke	≤0.10%
Nga poke katoa	≤0.50%
Ngaronga i te whakamaroke	≤0.50%
Te toenga i runga i te mura	≤0.10%
Nga Korewa Taamaha	≤0.001%
Te whakamatautau	98.0%~102.0%
Paerewa Whakamatau	Te Rongoa o te Pakeha (EP);United States Pharmacopoeia (USP)
Whakamahinga	Mahinga Rongoa Hohe (API)

Mōkī me te Rokiroki:

Mōkī: Pounamu, Peeke konumohe konumohe, Pahu Kaata, 25kg / Drum, kia rite ranei ki te hiahia a te kaihoko.

Tikanga Rokiroki:Whakaorangia i roto i nga ipu kua hiri ki te waahi makariri me te maroke;Whakaorangia mai i te marama, te makuku me te mate kino.

Painga:

FAQ:

Taupānga:

Ko Shanghai Ruifu Chemical Co., Ltd. te kaihanga matua me te kaiwhakarato o Glimepiride (CAS: 93479-97-1) me te kounga teitei, te whakauru rongoa kaha (API).Ko te Glimepiride he rongoa mo te mate huka e awhina ana ki te whakahaere i nga taumata huka toto.Ko te Glimepiride he sulfonylurea-whakatupuranga tuatoru me te mahi hypoglycemic.

Ko te Glimepiride (te ingoa hokohoko tuatahi ko Amaryl) he rongoa rongoa sulfonylurea-a-waha e waatea ana mo te mate huka.Pērā i ngā sulfonylureas katoa, ko te glimepiride te mahi hei mahi huna mo te insulin.Ka whakahekehia te huka toto ma te whakaihiihi i te tukunga o te insulin mai i nga pūtau beta pancreatic e mahi ana me te whakanui ake i te tairongo o nga kopa peripheral ki te insulin.Ka herea pea a Glimepiride ki nga kaiwhakawhiwhi hongere pāhare pāporo ATP-tairongo i runga i te mata o te pūtau pancreatic, ka whakaheke i te whakahaerenga pāhare pāporo me te whakaheke i te kiriuhi.Ko te whakahekenga o te membrane e whakaihiihi ana i te urunga katote konupūmā i roto i nga awa konupūmā ngaohiko-tairongo.Ko tenei pikinga o te konupūmā konupūmā kukū katote i roto i te pūtau ka whakaawe i te hunanga o te insulin.Ko te Glimepiride te nuinga e whakamahia ana ki te rongoa i nga turoro me te mate huka momo 2 ka taea hoki te whakaiti i te tupono ka pa mai te mate o te mate huka momo 2.I whakaaetia te tarukino e te FDA i te tau 1995 ka hangaia e Sanofi-Aventis.Ka taea te whakamahi i te taha o te kai tika me te kaupapa whakakori tinana, ka taea hoki te whakamahi mo ia anake, me etahi atu rongoa mate huka mena ka hiahiatia.Ka taea te whakamahi i te Glimepiride hei monotherapy me te whakakotahi ranei me te insulin.